Laura Calvo‐Barreiro

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

Sunny Malhotra, Carme Costa, Herena Eixarch et al. · Brain · 2020 · 127 citations · Full text

Immunology, Immune Regulation, Pathology +21

Metabolic responses of CHO cells to limitation of key amino acids

Tiago M. Duarte, Nuno Carinhas, Laura Calvo‐Barreiro et al. · Biotechnology and Bioengineering · 2014 · 104 citations

Glycobiology, Metabolic Model, Cellular Physiology +22

Metabolic signatures of GS‐CHO cell clones associated with butyrate treatment and culture phase transition

Nuno Carinhas, Tiago M. Duarte, Laura Calvo‐Barreiro et al. · Biotechnology and Bioengineering · 2013 · 103 citations · Full text

Engineering, Stationary Phase, Glycobiology +26

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

Laura Calvo‐Barreiro, Herena Eixarch, Manuel Ponce‐Alonso et al. · Cells · 2020 · 42 citations · Full text

Chitinase 3-like 1 is neurotoxic in primary cultured neurons

Clara Matute‐Blanch, Laura Calvo‐Barreiro, Iria Carballo‐Carbajal et al. · Scientific Reports · 2020 · 41 citations · Full text